Advisory Services Network’s Pacific Biosciences PACB Stock Holding History

Advisory Services Network’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25	Closed	-$33	–	3885
2026 Q1	$33	Buy	+25	New	+$45	﹤0.01%	4789
2021 Q3	–	Sell	-1,500	Closed	-$52K	–	2668
2021 Q2	$52K	Buy	+1,500	New	+$43.6K	﹤0.01%	1977
2020 Q4	–	Sell	-317	Closed	-$5.39K	–	3589
2020 Q3	$3K	Buy	+317	New	+$1.82K	﹤0.01%	2984

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Advisory Services Network's PACB Position: Q2 2026 in Review

Advisory Services Network sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 25 shares — an estimated $33 sold.

Advisory Services Network first reported a position in PACB in Q3 2020 and held it in 3 quarters. The position peaked at $52K in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Advisory Services Network reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 25 Pacific Biosciences shares in Q2 2026, an estimated $33.
Advisory Services Network first reported a position in Pacific Biosciences in Q3 2020 and held it in 3 quarters.
Advisory Services Network's Pacific Biosciences position peaked at $52K in Q2 2021.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.